Molecular signatures of inherited and acquired sporadic late onset
Por um escritor misterioso
Descrição
Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle fibers. Unlike iNM, SLONM is amenable to therapy. The distinction between these disorders is therefore crucial when the diagnosis remains ambiguous after initial investigations. We sought to identify biomarkers facilitating this distinction and to investigate the pathophysiology of nemaline rod formation in these different disorders. Twenty-two muscle samples from patients affected by SLONM or iNM underwent quantitative histological analysis, laser capture microdissection for proteomic analysis of nemaline rod areas and rod-free areas, and transcriptomic analysis. In all iNM samples, nemaline rods were found in subsarcolemmal or central aggregates, whereas they were diffusely distributed within muscle fibers in most SLONM samples. In SLONM, muscle fibers harboring nemaline rods were smaller than those without rods. Necrotic fibers, increased endomysial connective tissue, and atrophic fibers filled with nemaline rods were more common in SLONM. Proteomic analysis detected differentially expressed proteins between nemaline rod areas and rod-free areas, as well as between SLONM and iNM. These differentially expressed proteins implicated immune, structural, metabolic, and cellular processes in disease pathophysiology. Notably, immunoglobulin overexpression with accumulation in nemaline rod areas was detected in SLONM. Transcriptomic analysis corroborated proteomic findings and further revealed substantial gene expression differences between SLONM and iNM. Overall, we identified unique pathological and molecular signatures associated with SLONM and iNM, suggesting distinct underlying pathophysiological mechanisms. These findings represent a step towards enhanced diagnostic tools and towards development of treatments for SLONM.

Carcinogenesis: Mechanisms and Manifestations - Toxicologic Pathology

Frontiers Genetic and Epigenetic Interplay Define Disease Onset

IJMS, Free Full-Text
NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors

The etiology of clonal mosaicism in human aging and disease

Clonal Expansion in Cardiovascular Pathology

Epigenetics - Wikipedia

Clinicopathologic Profiles of Sporadic Late-Onset Nemaline

Molecular signatures of inherited and acquired sporadic late onset

Frontiers Molecular Signatures and Their Clinical Utility in

Figure 8 from Regional distribution of synaptic markers and APP

Molecular subtypes of ALS are associated with differences in

Diverse monogenic subforms of human spermatogenic failure

Integrative genetic analysis illuminates ALS heritability and identifies

Genetics of Alzheimer's Disease
de
por adulto (o preço varia de acordo com o tamanho do grupo)